Epilepsy in "Sunflower syndrome": electroclinical features, therapeutic response, and long-term follow-up.

Absence seizures Drug Eeg Epilepsy Epileptic syndromes Resistant seizures Sunflower syndrome

Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 10 06 2021
revised: 26 08 2021
accepted: 02 09 2021
pubmed: 16 10 2021
medline: 15 12 2021
entrez: 15 10 2021
Statut: ppublish

Résumé

Sunflower syndrome (SFS) is a rare childhood-onset generalized epilepsy characterized by photosensitivity, heliotropism, and drug-resistant stereotyped seizures maybe self-induced by hand-waving maneuvers. Data on the long-term prognosis are scantly and evidence over best treatment strategies is lacking. We retrospectively describe the electroclinical features, and therapeutic response in a group of 21 patients with SFS, without intellectual disability. 16 patients were female (67%), with a median age at onset of 7 years. In all patients, ictal episodes began with sun-staring, and hand-waving in front of the sunlight, accompanied by brief typical absence seizures. 17 patients (81%) showed interictal EEG abnormalities, mainly characterized by spike and polyspike-and-wave discharges. Ictal epileptiform activity occurred approximately less than one second after the start of hand-waving. At the last follow-up (median length 8.2 years), 12 patients (57%) were drug-resistant. Nine of them (75%) achieved seizure control with the use of tainted lenses, either alone or compared with anti-seizure medications (ASM). Disappearance of seizures was associated with EEG improvement/normalization when tinted glasses were used during EEG recordings. While the clinical and EEG characteristics of SFS are well defined, the best therapeutic approaches are still under debate. Our data confirms a high rate of drug-resistance and frequent need of polytherapy. Of note, in drug-resistant patients, lenses (but not ASM) were able to suppress PPR in our patients while wearing lenses. Regarding the role of lenses, we do not only rely on the PPR reduction but also clinically by the reduction of seizures. Although additional data are needed, lenses seem to have a powerful potential role for the management of SFS.

Sections du résumé

BACKGROUND BACKGROUND
Sunflower syndrome (SFS) is a rare childhood-onset generalized epilepsy characterized by photosensitivity, heliotropism, and drug-resistant stereotyped seizures maybe self-induced by hand-waving maneuvers. Data on the long-term prognosis are scantly and evidence over best treatment strategies is lacking.
METHODS METHODS
We retrospectively describe the electroclinical features, and therapeutic response in a group of 21 patients with SFS, without intellectual disability.
RESULTS RESULTS
16 patients were female (67%), with a median age at onset of 7 years. In all patients, ictal episodes began with sun-staring, and hand-waving in front of the sunlight, accompanied by brief typical absence seizures. 17 patients (81%) showed interictal EEG abnormalities, mainly characterized by spike and polyspike-and-wave discharges. Ictal epileptiform activity occurred approximately less than one second after the start of hand-waving. At the last follow-up (median length 8.2 years), 12 patients (57%) were drug-resistant. Nine of them (75%) achieved seizure control with the use of tainted lenses, either alone or compared with anti-seizure medications (ASM). Disappearance of seizures was associated with EEG improvement/normalization when tinted glasses were used during EEG recordings.
CONCLUSION CONCLUSIONS
While the clinical and EEG characteristics of SFS are well defined, the best therapeutic approaches are still under debate. Our data confirms a high rate of drug-resistance and frequent need of polytherapy. Of note, in drug-resistant patients, lenses (but not ASM) were able to suppress PPR in our patients while wearing lenses. Regarding the role of lenses, we do not only rely on the PPR reduction but also clinically by the reduction of seizures. Although additional data are needed, lenses seem to have a powerful potential role for the management of SFS.

Identifiants

pubmed: 34653789
pii: S1059-1311(21)00319-8
doi: 10.1016/j.seizure.2021.09.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-12

Informations de copyright

Copyright © 2021 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Vincenzo Belcastro (V)

Neurology Unit, Maggiore Hospital, Lodi, Italy. Electronic address: vincenzo.belcastro@asst-lodi.it.

Susanna Casellato (S)

Child Neuropsychiatry Unit, Epilepsy Center, University of Sassari, Sassari, Italy.

Pasquale Striano (P)

Department of Neurosciences, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health, University of Genoa, "G. Gaslini" Institute, Genova, Italy; Pediatric Neurology and Muscular Diseases Unit, IRCCS "G. Gaslini" Institute, Genova, Italy.

Giuseppe Capovilla (G)

Child Neuropsychiatry Department, Epilepsy Center, C. Poma Hospital, Mantova; Fondazione Poliambulanza, Brescia, Italy.

Salvatore Savasta (S)

Pediatric Clinic, ASST- di Crema, Crema, Italy.

Thomas Foiadelli (T)

Department of clinical, surgical, diagnostic and pediatric sciences, University of Pavia, Pavia, Italy.

Vito Sofia (V)

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia"; University of Catania, Catania, Italy.

Loretta Giuliano (L)

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia"; University of Catania, Catania, Italy.

Antonella Riva (A)

Department of Neurosciences, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health, University of Genoa, "G. Gaslini" Institute, Genova, Italy; Pediatric Neurology and Muscular Diseases Unit, IRCCS "G. Gaslini" Institute, Genova, Italy.

Maurizio Elia (M)

Unit of Neurology and Clinical Neurophysiopathology, Oasi Research Institute, IRCCS, Troina, EN, Italy.

Elisabetta Cesaroni (E)

Child Neuropsychiatric Unit, University of Ancona, Ancona, Italy.

Carlo Di Bonaventura (CD)

Epilepsy Unit, Department of Human Neurosciences, "Sapienza" University of Rome, Rome, Italy.

Teresa Giallonardo (T)

Epilepsy Centre, Department of Neuroscience, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.

Salvatore Striano (S)

Department of Medical and Surgical Sciences, Magna Græcia University; Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.

Antonio Gambardella (A)

Department of Medical and Surgical Sciences, Magna Græcia University; Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy.

Edoardo Ferlazzo (E)

Department of Medical and Surgical Sciences, Magna Græcia University; Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy; Regional Epilepsy Centre, Great Metropolitan "Bianchi-Melacrino-Morelli" Hospital, Reggio, Italy.

Alberto Verrotti (A)

Department of Pediatrics, University of Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH